Drug recall D-0097-2017

Class II Terminated reported Oct 19, 2016

Product

Marcaine 0.5% (bupivacaine HCl) injection, USP, 250 mg/50 mL (5 mg/mL), 50 mL Multiple-Dose Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1610-50.

Reason for recall

Lack of Assurance of Sterility and Subpotent Drug: defect in glass vial prevented stopper from forming a seal allowing water to ingress and dilute the product causing it to be less than the labeled potency.

Lots and codes

Lot #: 59310DD, Exp 1NOV2017

Recall details

Recalling firm
Hospira Inc., A Pfizer Company, Lake Forest, IL
Quantity
4768 vials
Distribution
Nationwide and Puerto Rico
Type
Voluntary: Firm initiated
Recall initiated
September 16, 2016
Terminated
July 31, 2019

Related products